MATER CHEM PHYS 润色咨询

MATERIALS CHEMISTRY AND PHYSICS

出版年份:1983 年文章数:10033 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:5.5% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2165690, encodeId=f52321656907f, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:腐蚀;金属材料;电化学<br>经验分享:算是正常速度,快慢看人品,不用过度相信别人评论。审稿人给的意见也很不错,不会很刁钻。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9c235557643, createdName=ms8000000715378889, createdTime=Mon Oct 30 11:02:14 CST 2023, time=2023-10-30, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=861022, encodeId=c75f86102223, content=审稿速度:2.0<br>经验分享:求助,在投稿过程中发现没有写“推荐审稿人”的地方,“推荐审稿人”应该放在哪里呢? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dd45414101, createdName=ms4600813998468978, createdTime=Tue May 26 17:19:38 CST 2020, time=2020-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094914, encodeId=c10e1094914d7, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094913, encodeId=7fec10949135b, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861509, encodeId=ce5c861509f5, content=112楼的,我也是做膜,你的现在接受了吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Sat Jun 06 11:30:54 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861972, encodeId=f5998619e29b, content=131楼,就是在coverletter里说明自己已经上传了 标红重新上传就好了.大家遇到已经上传声明又要求上传的,可以照此办法解决 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Tue Jun 16 15:44:41 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861896, encodeId=1e718618962b, content=审稿速度:1.0<br>经验分享:136楼愿意留个联系方式吗,状况差不多,with editor半个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e85414121, createdName=ms7933220824164544, createdTime=Mon Jun 15 08:22:41 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861897, encodeId=a90186189e6d, content=审稿速度:1.0<br>经验分享:136楼愿意留个联系方式吗,状况差不多,with editor半个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7055413998, createdName=ms1387707191880519, createdTime=Mon Jun 15 08:22:41 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861879, encodeId=ecd78618e935, content=审稿速度:1.0<br>经验分享:是的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Sun Jun 14 20:12:46 CST 2020, time=2020-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861775, encodeId=eeb5861e7561, content=审稿速度:1.0<br>经验分享:“please upload a conflict of interest form that has been signed by all the authors of the paper”请问大家,这个咋处理?是每个人签完名字后,再上传吗?. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae65413999, createdName=ms4600315023772712, createdTime=Fri Jun 12 09:13:20 CST 2020, time=2020-06-12, status=1, ipAttribution=)]
    2023-10-30 ms8000000715378889 来自辽宁省

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:腐蚀;金属材料;电化学
    经验分享:算是正常速度,快慢看人品,不用过度相信别人评论。审稿人给的意见也很不错,不会很刁钻。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2165690, encodeId=f52321656907f, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:腐蚀;金属材料;电化学<br>经验分享:算是正常速度,快慢看人品,不用过度相信别人评论。审稿人给的意见也很不错,不会很刁钻。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9c235557643, createdName=ms8000000715378889, createdTime=Mon Oct 30 11:02:14 CST 2023, time=2023-10-30, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=861022, encodeId=c75f86102223, content=审稿速度:2.0<br>经验分享:求助,在投稿过程中发现没有写“推荐审稿人”的地方,“推荐审稿人”应该放在哪里呢? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dd45414101, createdName=ms4600813998468978, createdTime=Tue May 26 17:19:38 CST 2020, time=2020-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094914, encodeId=c10e1094914d7, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094913, encodeId=7fec10949135b, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861509, encodeId=ce5c861509f5, content=112楼的,我也是做膜,你的现在接受了吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Sat Jun 06 11:30:54 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861972, encodeId=f5998619e29b, content=131楼,就是在coverletter里说明自己已经上传了 标红重新上传就好了.大家遇到已经上传声明又要求上传的,可以照此办法解决 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Tue Jun 16 15:44:41 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861896, encodeId=1e718618962b, content=审稿速度:1.0<br>经验分享:136楼愿意留个联系方式吗,状况差不多,with editor半个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e85414121, createdName=ms7933220824164544, createdTime=Mon Jun 15 08:22:41 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861897, encodeId=a90186189e6d, content=审稿速度:1.0<br>经验分享:136楼愿意留个联系方式吗,状况差不多,with editor半个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7055413998, createdName=ms1387707191880519, createdTime=Mon Jun 15 08:22:41 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861879, encodeId=ecd78618e935, content=审稿速度:1.0<br>经验分享:是的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Sun Jun 14 20:12:46 CST 2020, time=2020-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861775, encodeId=eeb5861e7561, content=审稿速度:1.0<br>经验分享:“please upload a conflict of interest form that has been signed by all the authors of the paper”请问大家,这个咋处理?是每个人签完名字后,再上传吗?. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae65413999, createdName=ms4600315023772712, createdTime=Fri Jun 12 09:13:20 CST 2020, time=2020-06-12, status=1, ipAttribution=)]
    2020-05-26 ms4600813998468978

    审稿速度:2.0
    经验分享:求助,在投稿过程中发现没有写“推荐审稿人”的地方,“推荐审稿人”应该放在哪里呢?

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2165690, encodeId=f52321656907f, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:腐蚀;金属材料;电化学<br>经验分享:算是正常速度,快慢看人品,不用过度相信别人评论。审稿人给的意见也很不错,不会很刁钻。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9c235557643, createdName=ms8000000715378889, createdTime=Mon Oct 30 11:02:14 CST 2023, time=2023-10-30, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=861022, encodeId=c75f86102223, content=审稿速度:2.0<br>经验分享:求助,在投稿过程中发现没有写“推荐审稿人”的地方,“推荐审稿人”应该放在哪里呢? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dd45414101, createdName=ms4600813998468978, createdTime=Tue May 26 17:19:38 CST 2020, time=2020-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094914, encodeId=c10e1094914d7, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094913, encodeId=7fec10949135b, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861509, encodeId=ce5c861509f5, content=112楼的,我也是做膜,你的现在接受了吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Sat Jun 06 11:30:54 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861972, encodeId=f5998619e29b, content=131楼,就是在coverletter里说明自己已经上传了 标红重新上传就好了.大家遇到已经上传声明又要求上传的,可以照此办法解决 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Tue Jun 16 15:44:41 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861896, encodeId=1e718618962b, content=审稿速度:1.0<br>经验分享:136楼愿意留个联系方式吗,状况差不多,with editor半个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e85414121, createdName=ms7933220824164544, createdTime=Mon Jun 15 08:22:41 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861897, encodeId=a90186189e6d, content=审稿速度:1.0<br>经验分享:136楼愿意留个联系方式吗,状况差不多,with editor半个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7055413998, createdName=ms1387707191880519, createdTime=Mon Jun 15 08:22:41 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861879, encodeId=ecd78618e935, content=审稿速度:1.0<br>经验分享:是的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Sun Jun 14 20:12:46 CST 2020, time=2020-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861775, encodeId=eeb5861e7561, content=审稿速度:1.0<br>经验分享:“please upload a conflict of interest form that has been signed by all the authors of the paper”请问大家,这个咋处理?是每个人签完名字后,再上传吗?. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae65413999, createdName=ms4600315023772712, createdTime=Fri Jun 12 09:13:20 CST 2020, time=2020-06-12, status=1, ipAttribution=)]
    2021-12-29 ms6000000264964247

    如何判断两种药物之间是协同作用还是相加作用?

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2165690, encodeId=f52321656907f, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:腐蚀;金属材料;电化学<br>经验分享:算是正常速度,快慢看人品,不用过度相信别人评论。审稿人给的意见也很不错,不会很刁钻。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9c235557643, createdName=ms8000000715378889, createdTime=Mon Oct 30 11:02:14 CST 2023, time=2023-10-30, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=861022, encodeId=c75f86102223, content=审稿速度:2.0<br>经验分享:求助,在投稿过程中发现没有写“推荐审稿人”的地方,“推荐审稿人”应该放在哪里呢? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dd45414101, createdName=ms4600813998468978, createdTime=Tue May 26 17:19:38 CST 2020, time=2020-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094914, encodeId=c10e1094914d7, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094913, encodeId=7fec10949135b, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861509, encodeId=ce5c861509f5, content=112楼的,我也是做膜,你的现在接受了吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Sat Jun 06 11:30:54 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861972, encodeId=f5998619e29b, content=131楼,就是在coverletter里说明自己已经上传了 标红重新上传就好了.大家遇到已经上传声明又要求上传的,可以照此办法解决 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Tue Jun 16 15:44:41 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861896, encodeId=1e718618962b, content=审稿速度:1.0<br>经验分享:136楼愿意留个联系方式吗,状况差不多,with editor半个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e85414121, createdName=ms7933220824164544, createdTime=Mon Jun 15 08:22:41 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861897, encodeId=a90186189e6d, content=审稿速度:1.0<br>经验分享:136楼愿意留个联系方式吗,状况差不多,with editor半个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7055413998, createdName=ms1387707191880519, createdTime=Mon Jun 15 08:22:41 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861879, encodeId=ecd78618e935, content=审稿速度:1.0<br>经验分享:是的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Sun Jun 14 20:12:46 CST 2020, time=2020-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861775, encodeId=eeb5861e7561, content=审稿速度:1.0<br>经验分享:“please upload a conflict of interest form that has been signed by all the authors of the paper”请问大家,这个咋处理?是每个人签完名字后,再上传吗?. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae65413999, createdName=ms4600315023772712, createdTime=Fri Jun 12 09:13:20 CST 2020, time=2020-06-12, status=1, ipAttribution=)]
    2021-12-27 乌云背后的幸福线

    上传文章有什么要求?

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2165690, encodeId=f52321656907f, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:腐蚀;金属材料;电化学<br>经验分享:算是正常速度,快慢看人品,不用过度相信别人评论。审稿人给的意见也很不错,不会很刁钻。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9c235557643, createdName=ms8000000715378889, createdTime=Mon Oct 30 11:02:14 CST 2023, time=2023-10-30, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=861022, encodeId=c75f86102223, content=审稿速度:2.0<br>经验分享:求助,在投稿过程中发现没有写“推荐审稿人”的地方,“推荐审稿人”应该放在哪里呢? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dd45414101, createdName=ms4600813998468978, createdTime=Tue May 26 17:19:38 CST 2020, time=2020-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094914, encodeId=c10e1094914d7, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094913, encodeId=7fec10949135b, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861509, encodeId=ce5c861509f5, content=112楼的,我也是做膜,你的现在接受了吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Sat Jun 06 11:30:54 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861972, encodeId=f5998619e29b, content=131楼,就是在coverletter里说明自己已经上传了 标红重新上传就好了.大家遇到已经上传声明又要求上传的,可以照此办法解决 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Tue Jun 16 15:44:41 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861896, encodeId=1e718618962b, content=审稿速度:1.0<br>经验分享:136楼愿意留个联系方式吗,状况差不多,with editor半个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e85414121, createdName=ms7933220824164544, createdTime=Mon Jun 15 08:22:41 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861897, encodeId=a90186189e6d, content=审稿速度:1.0<br>经验分享:136楼愿意留个联系方式吗,状况差不多,with editor半个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7055413998, createdName=ms1387707191880519, createdTime=Mon Jun 15 08:22:41 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861879, encodeId=ecd78618e935, content=审稿速度:1.0<br>经验分享:是的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Sun Jun 14 20:12:46 CST 2020, time=2020-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861775, encodeId=eeb5861e7561, content=审稿速度:1.0<br>经验分享:“please upload a conflict of interest form that has been signed by all the authors of the paper”请问大家,这个咋处理?是每个人签完名字后,再上传吗?. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae65413999, createdName=ms4600315023772712, createdTime=Fri Jun 12 09:13:20 CST 2020, time=2020-06-12, status=1, ipAttribution=)]
    2020-06-06 ms5469518383470847

    112楼的,我也是做膜,你的现在接受了吗

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2165690, encodeId=f52321656907f, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:腐蚀;金属材料;电化学<br>经验分享:算是正常速度,快慢看人品,不用过度相信别人评论。审稿人给的意见也很不错,不会很刁钻。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9c235557643, createdName=ms8000000715378889, createdTime=Mon Oct 30 11:02:14 CST 2023, time=2023-10-30, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=861022, encodeId=c75f86102223, content=审稿速度:2.0<br>经验分享:求助,在投稿过程中发现没有写“推荐审稿人”的地方,“推荐审稿人”应该放在哪里呢? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dd45414101, createdName=ms4600813998468978, createdTime=Tue May 26 17:19:38 CST 2020, time=2020-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094914, encodeId=c10e1094914d7, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094913, encodeId=7fec10949135b, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861509, encodeId=ce5c861509f5, content=112楼的,我也是做膜,你的现在接受了吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Sat Jun 06 11:30:54 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861972, encodeId=f5998619e29b, content=131楼,就是在coverletter里说明自己已经上传了 标红重新上传就好了.大家遇到已经上传声明又要求上传的,可以照此办法解决 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Tue Jun 16 15:44:41 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861896, encodeId=1e718618962b, content=审稿速度:1.0<br>经验分享:136楼愿意留个联系方式吗,状况差不多,with editor半个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e85414121, createdName=ms7933220824164544, createdTime=Mon Jun 15 08:22:41 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861897, encodeId=a90186189e6d, content=审稿速度:1.0<br>经验分享:136楼愿意留个联系方式吗,状况差不多,with editor半个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7055413998, createdName=ms1387707191880519, createdTime=Mon Jun 15 08:22:41 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861879, encodeId=ecd78618e935, content=审稿速度:1.0<br>经验分享:是的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Sun Jun 14 20:12:46 CST 2020, time=2020-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861775, encodeId=eeb5861e7561, content=审稿速度:1.0<br>经验分享:“please upload a conflict of interest form that has been signed by all the authors of the paper”请问大家,这个咋处理?是每个人签完名字后,再上传吗?. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae65413999, createdName=ms4600315023772712, createdTime=Fri Jun 12 09:13:20 CST 2020, time=2020-06-12, status=1, ipAttribution=)]
    2020-06-16 ms6032332839474392

    131楼,就是在coverletter里说明自己已经上传了 标红重新上传就好了.大家遇到已经上传声明又要求上传的,可以照此办法解决

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2165690, encodeId=f52321656907f, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:腐蚀;金属材料;电化学<br>经验分享:算是正常速度,快慢看人品,不用过度相信别人评论。审稿人给的意见也很不错,不会很刁钻。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9c235557643, createdName=ms8000000715378889, createdTime=Mon Oct 30 11:02:14 CST 2023, time=2023-10-30, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=861022, encodeId=c75f86102223, content=审稿速度:2.0<br>经验分享:求助,在投稿过程中发现没有写“推荐审稿人”的地方,“推荐审稿人”应该放在哪里呢? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dd45414101, createdName=ms4600813998468978, createdTime=Tue May 26 17:19:38 CST 2020, time=2020-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094914, encodeId=c10e1094914d7, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094913, encodeId=7fec10949135b, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861509, encodeId=ce5c861509f5, content=112楼的,我也是做膜,你的现在接受了吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Sat Jun 06 11:30:54 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861972, encodeId=f5998619e29b, content=131楼,就是在coverletter里说明自己已经上传了 标红重新上传就好了.大家遇到已经上传声明又要求上传的,可以照此办法解决 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Tue Jun 16 15:44:41 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861896, encodeId=1e718618962b, content=审稿速度:1.0<br>经验分享:136楼愿意留个联系方式吗,状况差不多,with editor半个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e85414121, createdName=ms7933220824164544, createdTime=Mon Jun 15 08:22:41 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861897, encodeId=a90186189e6d, content=审稿速度:1.0<br>经验分享:136楼愿意留个联系方式吗,状况差不多,with editor半个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7055413998, createdName=ms1387707191880519, createdTime=Mon Jun 15 08:22:41 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861879, encodeId=ecd78618e935, content=审稿速度:1.0<br>经验分享:是的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Sun Jun 14 20:12:46 CST 2020, time=2020-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861775, encodeId=eeb5861e7561, content=审稿速度:1.0<br>经验分享:“please upload a conflict of interest form that has been signed by all the authors of the paper”请问大家,这个咋处理?是每个人签完名字后,再上传吗?. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae65413999, createdName=ms4600315023772712, createdTime=Fri Jun 12 09:13:20 CST 2020, time=2020-06-12, status=1, ipAttribution=)]
    2020-06-15 ms7933220824164544

    审稿速度:1.0
    经验分享:136楼愿意留个联系方式吗,状况差不多,with editor半个多月了

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2165690, encodeId=f52321656907f, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:腐蚀;金属材料;电化学<br>经验分享:算是正常速度,快慢看人品,不用过度相信别人评论。审稿人给的意见也很不错,不会很刁钻。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9c235557643, createdName=ms8000000715378889, createdTime=Mon Oct 30 11:02:14 CST 2023, time=2023-10-30, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=861022, encodeId=c75f86102223, content=审稿速度:2.0<br>经验分享:求助,在投稿过程中发现没有写“推荐审稿人”的地方,“推荐审稿人”应该放在哪里呢? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dd45414101, createdName=ms4600813998468978, createdTime=Tue May 26 17:19:38 CST 2020, time=2020-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094914, encodeId=c10e1094914d7, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094913, encodeId=7fec10949135b, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861509, encodeId=ce5c861509f5, content=112楼的,我也是做膜,你的现在接受了吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Sat Jun 06 11:30:54 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861972, encodeId=f5998619e29b, content=131楼,就是在coverletter里说明自己已经上传了 标红重新上传就好了.大家遇到已经上传声明又要求上传的,可以照此办法解决 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Tue Jun 16 15:44:41 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861896, encodeId=1e718618962b, content=审稿速度:1.0<br>经验分享:136楼愿意留个联系方式吗,状况差不多,with editor半个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e85414121, createdName=ms7933220824164544, createdTime=Mon Jun 15 08:22:41 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861897, encodeId=a90186189e6d, content=审稿速度:1.0<br>经验分享:136楼愿意留个联系方式吗,状况差不多,with editor半个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7055413998, createdName=ms1387707191880519, createdTime=Mon Jun 15 08:22:41 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861879, encodeId=ecd78618e935, content=审稿速度:1.0<br>经验分享:是的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Sun Jun 14 20:12:46 CST 2020, time=2020-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861775, encodeId=eeb5861e7561, content=审稿速度:1.0<br>经验分享:“please upload a conflict of interest form that has been signed by all the authors of the paper”请问大家,这个咋处理?是每个人签完名字后,再上传吗?. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae65413999, createdName=ms4600315023772712, createdTime=Fri Jun 12 09:13:20 CST 2020, time=2020-06-12, status=1, ipAttribution=)]
    2020-06-15 ms1387707191880519

    审稿速度:1.0
    经验分享:136楼愿意留个联系方式吗,状况差不多,with editor半个多月了

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2165690, encodeId=f52321656907f, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:腐蚀;金属材料;电化学<br>经验分享:算是正常速度,快慢看人品,不用过度相信别人评论。审稿人给的意见也很不错,不会很刁钻。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9c235557643, createdName=ms8000000715378889, createdTime=Mon Oct 30 11:02:14 CST 2023, time=2023-10-30, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=861022, encodeId=c75f86102223, content=审稿速度:2.0<br>经验分享:求助,在投稿过程中发现没有写“推荐审稿人”的地方,“推荐审稿人”应该放在哪里呢? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dd45414101, createdName=ms4600813998468978, createdTime=Tue May 26 17:19:38 CST 2020, time=2020-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094914, encodeId=c10e1094914d7, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094913, encodeId=7fec10949135b, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861509, encodeId=ce5c861509f5, content=112楼的,我也是做膜,你的现在接受了吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Sat Jun 06 11:30:54 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861972, encodeId=f5998619e29b, content=131楼,就是在coverletter里说明自己已经上传了 标红重新上传就好了.大家遇到已经上传声明又要求上传的,可以照此办法解决 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Tue Jun 16 15:44:41 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861896, encodeId=1e718618962b, content=审稿速度:1.0<br>经验分享:136楼愿意留个联系方式吗,状况差不多,with editor半个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e85414121, createdName=ms7933220824164544, createdTime=Mon Jun 15 08:22:41 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861897, encodeId=a90186189e6d, content=审稿速度:1.0<br>经验分享:136楼愿意留个联系方式吗,状况差不多,with editor半个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7055413998, createdName=ms1387707191880519, createdTime=Mon Jun 15 08:22:41 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861879, encodeId=ecd78618e935, content=审稿速度:1.0<br>经验分享:是的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Sun Jun 14 20:12:46 CST 2020, time=2020-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861775, encodeId=eeb5861e7561, content=审稿速度:1.0<br>经验分享:“please upload a conflict of interest form that has been signed by all the authors of the paper”请问大家,这个咋处理?是每个人签完名字后,再上传吗?. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae65413999, createdName=ms4600315023772712, createdTime=Fri Jun 12 09:13:20 CST 2020, time=2020-06-12, status=1, ipAttribution=)]
    2020-06-14 ms5624929764890046

    审稿速度:1.0
    经验分享:是的

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2165690, encodeId=f52321656907f, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:腐蚀;金属材料;电化学<br>经验分享:算是正常速度,快慢看人品,不用过度相信别人评论。审稿人给的意见也很不错,不会很刁钻。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9c235557643, createdName=ms8000000715378889, createdTime=Mon Oct 30 11:02:14 CST 2023, time=2023-10-30, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=861022, encodeId=c75f86102223, content=审稿速度:2.0<br>经验分享:求助,在投稿过程中发现没有写“推荐审稿人”的地方,“推荐审稿人”应该放在哪里呢? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2dd45414101, createdName=ms4600813998468978, createdTime=Tue May 26 17:19:38 CST 2020, time=2020-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094914, encodeId=c10e1094914d7, content=如何判断两种药物之间是协同作用还是相加作用?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1094913, encodeId=7fec10949135b, content=上传文章有什么要求?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861509, encodeId=ce5c861509f5, content=112楼的,我也是做膜,你的现在接受了吗 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fcaa5413987, createdName=ms5469518383470847, createdTime=Sat Jun 06 11:30:54 CST 2020, time=2020-06-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861972, encodeId=f5998619e29b, content=131楼,就是在coverletter里说明自己已经上传了 标红重新上传就好了.大家遇到已经上传声明又要求上传的,可以照此办法解决 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d6c5414003, createdName=ms6032332839474392, createdTime=Tue Jun 16 15:44:41 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861896, encodeId=1e718618962b, content=审稿速度:1.0<br>经验分享:136楼愿意留个联系方式吗,状况差不多,with editor半个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17e85414121, createdName=ms7933220824164544, createdTime=Mon Jun 15 08:22:41 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861897, encodeId=a90186189e6d, content=审稿速度:1.0<br>经验分享:136楼愿意留个联系方式吗,状况差不多,with editor半个多月了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7055413998, createdName=ms1387707191880519, createdTime=Mon Jun 15 08:22:41 CST 2020, time=2020-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861879, encodeId=ecd78618e935, content=审稿速度:1.0<br>经验分享:是的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13ef5414127, createdName=ms5624929764890046, createdTime=Sun Jun 14 20:12:46 CST 2020, time=2020-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=861775, encodeId=eeb5861e7561, content=审稿速度:1.0<br>经验分享:“please upload a conflict of interest form that has been signed by all the authors of the paper”请问大家,这个咋处理?是每个人签完名字后,再上传吗?. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ae65413999, createdName=ms4600315023772712, createdTime=Fri Jun 12 09:13:20 CST 2020, time=2020-06-12, status=1, ipAttribution=)]
    2020-06-12 ms4600315023772712

    审稿速度:1.0
    经验分享:“please upload a conflict of interest form that has been signed by all the authors of the paper”请问大家,这个咋处理?是每个人签完名字后,再上传吗?.

    0

共166条页码: 1/17页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分